Cargando…

A comparison of AAV-vector production methods for gene therapy and preclinical assessment

Adeno Associated Virus (AAV)-mediated gene expression in the brain is widely applied in the preclinical setting to investigate the therapeutic potential of specific molecular targets, characterize various cellular functions, and model central nervous system (CNS) diseases. In therapeutic application...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davidsson, Marcus, Negrini, Matilde, Hauser, Swantje, Svanbergsson, Alexander, Lockowandt, Marcus, Tomasello, Giuseppe, Manfredsson, Fredric P., Heuer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726153/ https://www.ncbi.nlm.nih.gov/pubmed/33299011 http://dx.doi.org/10.1038/s41598-020-78521-w

Ejemplares similares

Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
por: Negrini, Matilde, et al.
Publicado: (2022)

Small scale adeno-associated virus-vector production for preclinical gene delivery based on chloroform precipitation
por: Davidsson, Marcus, et al.
Publicado: (2021)

Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
por: Gubinelli, F., et al.
Publicado: (2022)

Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
por: Chatterjee, Diptaman, et al.
Publicado: (2021)

A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism
por: Davidsson, Marcus, et al.
Publicado: (2019)

Targeted Gene Delivery to the Enteric Nervous System Using AAV: A Comparison Across Serotypes and Capsid Mutants
por: Benskey, Matthew J, et al.
Publicado: (2015)

A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates
por: Anwer, Danish M., et al.
Publicado: (2023)

Gene therapy of adeno‐associated virus (AAV) vectors in preclinical models of ischemic stroke
por: Wang, Jing, et al.
Publicado: (2023)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors
por: Björklund, Tomas, et al.
Publicado: (2021)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons
por: Aldrin-Kirk, Patrick, et al.
Publicado: (2014)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia A
por: Elkouby, Liron, et al.
Publicado: (2021)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing
por: Davidsson, Marcus, et al.
Publicado: (2018)

Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs
por: Pleticha, Josef, et al.
Publicado: (2014)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells
por: Blessing, Daniel, et al.
Publicado: (2018)

AAV vector production: Troublesome host innate responses in another setting
por: Wright, J. Fraser
Publicado: (2023)

AAV vector production: Troublesome host innate responses in another setting
por: Wright, J. Fraser
Publicado: (2023)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production
por: Halbert, Christine L., et al.
Publicado: (2010)

A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2017)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

Goody two plasmids: An optimized transient transfection system for AAV vector production
por: Moreno Velasquez, Sergio David, et al.
Publicado: (2023)

Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System
por: Gombash, Sara E., et al.
Publicado: (2013)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
por: Orlowski, Alejandro, et al.
Publicado: (2020)

Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?
por: Kanaan, Nicholas M., et al.
Publicado: (2012)

AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector
por: Petersen-Jones, S.M., et al.
Publicado: (2009)

AAV Vectors Vaccines Against Infectious Diseases
por: Nieto, Karen, et al.
Publicado: (2014)

AAV vector-mediated in vivo reprogramming into pluripotency
por: Senís, Elena, et al.
Publicado: (2018)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences
por: Shi, Shuiliang, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pvop9pgnm515vekidbgjibb6gt